Clin Endosc.  2018 Sep;51(5):402-403. 10.5946/ce.2018.098.

The More, the Better: Is This True in Endoscopy for Gastric Cancer Screening?

• Jeon SW

• KMID: 2427710
• DOI: http://doi.org/10.5946/ce.2018.098

Abstract

No abstract available.

MeSH Terms

Endoscopy*
Mass Screening*
Stomach Neoplasms*

Reference

1. Gong EJ, Ahn JY, Jung HY, et al. Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. J Gastroenterol Hepatol. 2014; 29:301–309.

2. Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality. Gastroenterology. 2017; 152:1319–1328.e7.

3. Mun YG, Choi MG, Lee HY, et al. Factors affecting endoscopic curative resection of gastric cancer in the population-based screening era. Clin Endosc. 2018; 51:478–484.

4. Jin S, Jeon SW, Kwon Y, et al. Optimal endoscopic screening interval for early detection of gastric cancer: a single-center study. J Korean Med Sci. 2018; 33:e166.

5. Yoon H, Kim N, Lee HS, et al. Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. J Gastroenterol Hepatol. 2012; 27:928–934.

6. Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician. 2001; 63:513–522.

7. Kim SG, Ji SM, Lee NR, et al. Quality of life after endoscopic submucosal dissection for early gastric cancer: a prospective multicenter cohort study. Gut Liver. 2017; 11:87–92.